On the contrary, treatment with 2-methylestradiol diminished HIF-1α expression, reduced collagen synthesis, fibrocyte proliferation in fibroblasts, suggesting that targeting HIF-1α may give potential for treatment of SSc (161). The gene discussed is HIF1A; the disease is systemic sclerosis.